Study on Route Selection of Systematization of Drug Patent Linkage in China
Xie Wei1,2, Ma Zhiguo1, Zhang Lei1
1. School of Law, Xi'an Jiaotong University, Xi'an 710049, China; 2. College of Medicine and Phamacy, Shaanxi Institute of International Trade and Commerce, Xi'an 712046, China
Abstract：The accessibility of medicines is a basic evaluation indicator of public health and well-being.Availability and affordability separate the two ends of drug accessibility.Balancing the interests of the two ends of drug accessibility dynamically is regarded as the criterion of drug patent linkage system.To a certain extent, the previous revisions of Patent Law of China have promoted the process of drug patent linkage, and the relevant policies and regulations in the field of drugs are also exploring the possibility of drug patent linkage gradually.Through the comparative analysis of the mode of drug patent association outside the region, it is found that compared with the mode of independent operation of drug patent, the mode of drug patent linkage system is more conducive to promoting the development of innovative drug industry.However, China's drug patent linkage has not reached the level of systematization at present, and there are a series of difficulties.Therefore, we should construct a drug patent linkage system with Chinese characteristics from the aspects of relevant legislation, registration and publicity, linkage mechanism, decision mechanism and duration of rights.
谢伟, 马治国, 张磊. 中国药品专利链接体系化的路径选择研究[J]. 中国科技论坛, 2021(5): 108-117.
Xie Wei, Ma Zhiguo, Zhang Lei. Study on Route Selection of Systematization of Drug Patent Linkage in China. , 2021(5): 108-117.
2021, 
